Brian Mueller, EVP, Chief Financial Officer at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 5,000 shares at $75.19 ($376K) on 2024-05-30, disclosed to the SEC on 2024-05-31.
Scheduled sale ($376k) by EVP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BMRN | SELL | 2022-12-06 | $1.5M | — | Filing → |
| BMRN | SELL | 2022-11-28 | $714K | — | Filing → |
| BMRN | SELL | 2022-08-09 | $331K | — | Filing → |